Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
5.1 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Naloxone or other opioid antagonist; possession and administration, liability. | Naloxone; possession and administration. Provides that a person who is not otherwise authorized to administer naloxone or other opioid antagonist used for overdose reversal may administer naloxone or other opioid antagonist used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose, provided that the administration is in good faith and absent gross negligence or willful and wanton misconduct. | us/states/va | Virginia General Assembly | 2020 | SB 566 | Virginia SB 566 (2020) |
|
enacted |
|
4 | 29 | 6 | 2020-01-07 | 2020-04-10 | openstates | ocd-bill/f8173f3b-a3ea-4a9e-a468-7b122f697934 | https://lis.virginia.gov/cgi-bin/legp604.exe?201+sum+SB566 | c26767049261b959d5fb5a3eaab8a29fc602ea2f0716fc8acd388359c7cf5680 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 566 (2020) — Naloxone or other opioid antagonist; possession and administration, liability.
Naloxone; possession and administration. Provides that a person who is not otherwise authorized to administer naloxone or other opioid antagonist used for overdose reversal may administer naloxone or other opioid antagonist used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose, provided that the administration is in good faith and absent gross negligence or willful and wanton misconduct.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Acts of Assembly Chapter text (CHAP1095) (committee substitute) — source
- Bill text as passed Senate and House (SB566ER) (committee substitute) — source
- Engrossed by Senate as amended SB566E (committee substitute) — source
- Impact statement from DPB (SB566) (committee substitute) — source
Votes
- Constitutional reading dispensed (37-Y 0-N) — 37–0 (pass) · upper
- Constitutional reading dispensed (39-Y 0-N) — 39–0 (pass) · upper
- Passed Senate (39-Y 0-N) — 39–0 (pass) · upper
- Reported from Health, Welfare and Institutions (22-Y 0-N) — 22–0 (pass) · lower
- VOTE: Block Vote Passage (100-Y 0-N) — 99–0 (pass) · lower
- Reported from Education and Health with amendment (15-Y 0-N) — 15–0 (pass) · upper
Sponsors
- John S. Edwards — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2020-01-07 Prefiled and ordered printed; offered 01/08/20 20104900D
introduction - 2020-01-07 Referred to Committee on Education and Health
referral-committee - 2020-01-27 Assigned Education sub: Health Professions
referral-committee - 2020-01-28 Impact statement from DPB (SB566)
- 2020-02-06 Reported from Education and Health with amendment (15-Y 0-N)
committee-passage - 2020-02-07 Constitutional reading dispensed (37-Y 0-N)
- 2020-02-10 Read second time
reading-2 - 2020-02-10 Reading of amendment waived
- 2020-02-10 Committee amendment agreed to
- 2020-02-10 Engrossed by Senate as amended SB566E
- 2020-02-10 Constitutional reading dispensed (39-Y 0-N)
- 2020-02-10 Passed Senate (39-Y 0-N)
passage - 2020-02-10 Printed as engrossed 20104900D-E
- 2020-02-11 Impact statement from DPB (SB566E)
- 2020-02-18 Placed on Calendar
- 2020-02-18 Read first time
reading-1 - 2020-02-18 Referred to Committee on Health, Welfare and Institutions
referral-committee - 2020-02-25 Reported from Health, Welfare and Institutions (22-Y 0-N)
committee-passage - 2020-02-27 Read second time
reading-2 - 2020-02-28 Read third time
reading-3 - 2020-02-28 Passed House BLOCK VOTE (100-Y 0-N)
passage - 2020-02-28 VOTE: Block Vote Passage (100-Y 0-N)
- 2020-03-05 Enrolled
- 2020-03-05 Impact statement from DPB (SB566ER)
- 2020-03-06 Signed by Speaker
- 2020-03-07 Signed by President
- 2020-03-12 Enrolled Bill Communicated to Governor on March 12, 2020
- 2020-03-12 Governor's Action Deadline 11:59 p.m., April 11, 2020
- 2020-04-10 Approved by Governor-Chapter 1095 (effective 7/1/20)
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/f8173f3b-a3ea-4a9e-a468-7b122f697934. Confidence: reported (aggregated from official Virginia legislature records).